The latest trading day saw Hims & Hers Health, Inc. (HIMS) settling at $42.20, representing a +0.84% change from its…
The latest trading day saw Hims & Hers Health, Inc. (HIMS) settling at $42.20, representing a +0.84% change from its…
We recently compiled a list of the Jim Cramer Shed Light on These 8 Stocks Recently. In this article, we…
We recently compiled a list of the Jim Cramer Shed Light on These 8 Stocks Recently. In this article, we are…
We recently published a list of 12 Best Beauty Stocks to Buy According to Hedge Funds. In this article, we…
Hims & Hers introduces Health Collective ambassador program and Community Member Council, offering exclusive product access and direct input into…
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced two new…
Hims & Hers Health, Inc. ( NYSE:HIMS ) shares have continued their recent momentum with a 46% gain in the…
Hims & Hers Health, Inc. , the leading health and wellness platform, today announced that it will report fourth quarter…
SAN FRANCISCO--(BUSINESS WIRE)--Feb 3, 2025--…
Hims & Hers Health to report Q4 and full-year 2024 results on February 24, followed by conference call. Management to…
Hims & Hers Health (NYSE:HIMS) Trading Up 4.5% - Heres What Happened…
We recently compiled a list of the 5 Stocks That Started The Year On A High. In this article, we…
We recently compiled a list of the 5 Stocks That Started The Year On A High. In this article, we…
Anyone who’s looked at the market in the last couple of weeks will know that there were some events that…
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the…
Means Investment CO. Inc. grew its stake in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 23.5%…
Perigon Wealth Management LLC bought a new stake in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) in…
We recently compiled a list of the 12 Best Booming Stocks to Invest in Now. In this article, we are…
We recently compiled a list of the 12 Best Booming Stocks to Invest in Now. In this article, we are going…
Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) was the target of a large growth in short interest…
We recently published a list of 10 Firms Buck Market Slump on Impressive Earnings, New Deals. In this article, we…
We recently published a list of 10 Firms Buck Market Slump on Impressive Earnings, New Deals. In this article, we…
Hims & Hers Health (NYSE:HIMS) Reaches New 12-Month High - Heres Why…
EMC Capital Management reduced its position in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 76.8% during…
In a remarkable display of market confidence, HIMS & Hers Health, Inc. (HIMS) stock has soared to an all-time high,…
Telehealth company Him & Hers Health is taking a much different approach to their Super Bowl ad this year.…
Baader Bank Aktiengesellschaft lowered its position in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 55.2% during…
Hims & Hers releases Super Bowl ad criticizing pharmaceutical industry and weight loss market, promoting their compounded GLP-1 drugs while…
HIMS is enhancing its offerings and expanding the breadth of health and wellness products and services. However, macro challenges are…
HIMS is enhancing its offerings and expanding the breadth of health and wellness products and services. However, macro challenges are…
Hims & Hers Health, Inc. (HIMS) concluded the recent trading session at $31.86, signifying a +1.01% move from its prior…
Hims & Hers Health, Inc. (HIMS) closed the latest trading day at $31.86, indicating a +1.01% change from the previous…
A Super Bowl ad for weight loss medications from telehealth company Hims & Hers is optimized to engage and infuriate…
Genesee Capital Advisors LLC bought a new stake in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) during…
Telehealth company Hims & Hers is playing offense in a new commercial slated to air during the Super Bowl next…
Hims & Hers may leverage FDA compounding exemptions to further extend its compounded GLP-1 offerings. Learn why HIMS stock is…
Telehealth companys spot decries medications from others as "priced for profits, not patients," while its own weight-loss drugs are "affordable."…
Hims & Hers Health (NYSE:HIMS) Trading 5.7% Higher - Still a Buy?…
Hims & Hers’ decision to advertise at the Super Bowl represents an ambitious play for the brand as it positions…
Super Bowl als Bühne: Der Spot hebt Hims & Hers als Anbieter preiswerter und patientenorientierter Lösungen hervor – eine…